June 9 (Reuters) – Privately held Element Biosciences said on Tuesday it had raised funds, including $175 million from longtime investor Samsung Electronics, to expand commercialisation of its genetic
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Iranian director brings tale of despair and resilience to Venice
By Crispian Balmer VENICE, Sept 11 (Reuters) - Repression, conflict and political upheaval at home…
Anthropic disrupts bioweapons research efforts, Russian hacking, Chinese Claude misuse
By AJ Vicens and Eduardo Baptista Sept 10 (Reuters) - Anthropic broke up attempts to…
US consumer inflation picks up in August
By Lucia Mutikani WASHINGTON, Sept 11 (Reuters) - U.S. consumer prices accelerated in August, while…
